TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
NTRA

Natera Inc

Healthcare · Diagnostics & Research

408.80$ +4.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Natera Inc (NTRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 753 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement NTRA
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
54 49 47 54 57 54 62 63 65 67 67 74 78 83 94 86 98 112 152 142 158 173 194 198 211 217 242 261 268 311 368 413 440 476 502 547 592 666 697 753 2,707
34 38 34 35 35 37 41 41 42 43 43 44 44 44 45 47 52 60 67 76 81 94 103 109 117 127 148 143 147 151 159 170 168 176 185 200 208 219 245 268 939
20 11 13 19 22 17 22 22 24 24 24 31 34 39 49 40 46 52 86 66 77 79 91 89 94 90 94 118 121 160 209 243 272 300 317 347 384 447 451 485 1,768
11 11 13 12 13 13 14 12 12 13 11 12 13 15 18 23 26 32 40 54 98 72 80 83 66 88 82 78 77 83 89 89 97 129 129 146 173 175 211 228 787
35 37 38 34 34 48 38 37 38 41 44 47 57 59 66 68 76 94 108 127 128 147 148 149 148 144 150 153 155 161 194 198 214 235 267 311 309 291 328 327 1,255
46 49 50 46 47 62 52 49 51 54 55 59 55 74 84 91 102 126 149 181 227 219 228 232 213 232 232 231 232 244 283 287 311 364 396 457 482 470 545 561 2,058
-27 -38 -37 -27 -25 -45 -31 -27 -27 -30 -32 -29 -21 -35 -35 -52 -56 -74 -63 -115 -150 -140 -137 -143 -119 -142 -138 -112 -111 -85 -74 -44 -39 -65 -79 -110 -98 -23 -94 -76 -290
0.1 0.2 0.2 0.2 1.5 2.3 2.4 2.6 2.8 2.7 2.7 2.7 2.7 2.6 2.5 4.0 4.3 4.3 2.1 2.1 2.1 2.1 2.1 2.2 2.3 2.8 3.1 3.2 3.3 3.1 3.1 3.1 3.1 1.3 1.0 1.0 1.0 7.1 0.9 0.9 10.0
-26 -38 -36 -28 -27 -45 -33 -34 -29 -32 -34 -31 -23 -35 -35 -60 -58 -76 -64 -116 -151 -141 -138 -145 -121 -142 -137 -111 -109 -78 -67 -37 -31 -55 -67 -101 -87 -13 -85 -67 -253
0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.2 0.2 0.4 0.2 -0.3 0.2 0.2 0.4 0.9 0.7 -1.4 0.2 0.3 0.2 -61 0.3 -0.3 -60
-26 -38 -36 -28 -27 -46 -33 -34 -30 -32 -34 -32 -23 -35 -35 -60 -58 -76 -64 -116 -151 -141 -139 -145 -121 -143 -137 -111 -109 -78 -68 -37 -32 -54 -67 -101 -88 47 -85 -67 -192
-24 -36 -34 -27 -24 -41 -29 -29 -25 -27 -29 -26 -18 -31 -31 -53 -52 -70 -56 -108 -143 -136 -130 -135 -110 -132 -125 -99 -95 -64 -53 -26 -20 -46 -57 -90 -76 7.9 -65 -45 -179

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?